ADVERTISEMENT
Bill Clinton admits that she tested positive for …
President Donald Trump signed an executive order Saturday that he said “directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs.” A primary objective of the order is to speed treatment for veterans.
The president said the executive order would implement “historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs.” Citing the elevated veteran suicide rate, the president added: “In many cases, these experimental treatments have shown life-changing potential for those suffering from severe mental illness and depression, including our cherished veterans.”
“And the nice part is we’re actually doing this early, but it has been going on
Research has been going on for quite some time. But, you know, usually with things like this, nothing ever happens, no matter how the research ends up, but we’re changing that. This order will clear away unnecessary bureaucratic hurdles, improve data sharing among the FDA and the Department of Veterans Affairs, and facilitate fast rescheduling of any psychedelic drugs that become FDA approved,” Trump continued.
And today, the federal government is making a $50 million research investment in its own. And so that was just approved just last night,” Trump announced.
ADVERTISEMENT
